
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem. RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0019 | 0.205405405405 | 0.925 | 1 | 0.91 | 50477 | 0.94623317 | CS |
4 | -0.1931 | -17.2410714286 | 1.12 | 1.18 | 0.8801 | 143014 | 1.0257806 | CS |
12 | -0.2931 | -24.0245901639 | 1.22 | 1.6899 | 0.8801 | 136635 | 1.20541576 | CS |
26 | -0.1631 | -14.9633027523 | 1.09 | 1.6899 | 0.7736 | 93155 | 1.20335672 | CS |
52 | -0.7931 | -46.1104651163 | 1.72 | 1.8201 | 0.7736 | 65793 | 1.19768356 | CS |
156 | -2.3631 | -71.8267477204 | 3.29 | 5.745 | 0.5306 | 97509 | 2.14153406 | CS |
260 | -7.3231 | -88.7648484848 | 8.25 | 16.74 | 0.5306 | 370819 | 7.44207551 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions